Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:43 PM
NCT ID:
NCT00078806
Eligibility Criteria:
INCLUSION CRITERIA:
* 2 - 18 years of age
* SOJRA for at least 3 months, with stable systemic features
* If taking methotrexate, hydroxychloroquine, or NSAIDs, dose must be stable
* Must take prednisone at a stable dose
EXCLUSION CRITERIA:
* Need for other DMARDs or prestudy requirements for oral or parenteral pulse steroids or intra-articular steroids
* Pregnant or nursing female
* Clinically significant abnormal laboratory test results for blood cells, liver or kidney function, or serology
* Previous receipt of any tumor necrosis factor (TNF) inhibitor
* Live virus vaccine within 12 weeks of study entry
* Participation in another study requiring informed consent within 12 weeks of entry
* Diabetes that requires insulin treatment
* Infection, chronic, recurrent, or currently active
* Any serious medical or psychiatric condition or history of alcohol or drug abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
18 Years
Study:
NCT00078806
Study Brief:
Protocol Section:
NCT00078806